Fig. 2: Pharmacological characterization of the APLNR-cpGFP biosensors.
From: In vivo measurement of an Apelin gradient with a genetically encoded APLNR conformation biosensor
Stimulation with Apelin and Apela (arrow indicates timepoint of ligand addition) led to a significant increase of APLNR(F233)-cpGFP (a, c) and APLNR(K235)-cpGFP (b, d) biosensor fluorescent intensity. The APLNR antagonist ML-221 significantly diminished the Apelin-induced fluorescent response of APLNR(F233)-cpGFP (e) and APLNR(K235)-cpGFP (f). Data are presented as mean values ± SEM from three independent experiments conducted in stable APLNR-cpGFP expressing HEK293T cells. cpGFP circularly permuted GFP, HEK293T human embryonic kidney 293T. Source data are provided as a Source Data file.
